Epizyme To Report Fourth Quarter 2014 Financial Results And Provide Corporate Update On March 12, 2015

izyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it will host a conference call and live audio webcast on Thursday, March 12, 2015, at 7:30 a.m. ET to report fourth quarter 2014 financial results and provide a corporate update.

Help employers find you! Check out all the jobs and post your resume.